Related Experiment Video
Updated: Aug 21, 2026

Daily Phototherapy with Red Light to Regulate Candida albicans Biofilm Growth
Published on: April 23, 2019
[Sepsis by Candida in VLBW neonates: therapy with liposomal Amphotericin B]
E Occhipinti1, T Caravello, N Ciminello
1Unità Operativa di Terapia Intensiva Neonatale e Neonatologia, Ospedale G. F. Ingrassia, Azienda USL 6, Palermo.
Abstract:
Candida spp. are recently frequent cause of nosocomial sepsis in neonates admitted in NICU, expecially VLBW. Amphotericin B is used in the treament of infections caused by Candida, but heavy side effects, expecially due to renal toxiticy, prevent often its use in the VLBW neonates. We used a new formulation of Amphotericin (AmBisome--NEXSTAR), in the treatment of 17 VLBW neonates affected by sepsis caused by Candida albicans, admitted in our NICU during two years. Twelve neonates survived, one neonate died for NEC and bowel perforation. The treatment was prolonged for 13 days (7-33 days), the total amount of dose was 65 mg/Kg, none side effect was noted.
Related Concept Videos
Candidiasis
Antifungal Agents
Cryptococcal Meningitis
Development of the Oral Microbiota
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...